tiprankstipranks
Trending News
More News >

InhaleRx Limited Announces Shareholder Webinar to Discuss Clinical Progress

Story Highlights
InhaleRx Limited Announces Shareholder Webinar to Discuss Clinical Progress

Confident Investing Starts Here:

InhaleRx Limited ( (AU:IRX) ) has issued an announcement.

InhaleRx Limited has announced a shareholder town hall webinar scheduled for March 13, 2025, where the company’s CEO and Medical Advisor will provide updates on recent developments and progress in their clinical development program. This event highlights InhaleRx’s ongoing efforts to strengthen its position in the healthcare industry by addressing unmet medical needs and pursuing significant economic opportunities for its shareholders.

More about InhaleRx Limited

InhaleRx Limited is an Australian healthcare company focused on developing unique inhaled drug-device products targeting unmet medical needs in the pain management and mental health sectors. The company aims to secure U.S. FDA approval through rapid and cost-effective regulatory pathways, with a focus on Breakthrough Cancer Pain and Panic Disorder, both of which have limited treatment options.

YTD Price Performance: -32.50%

Average Trading Volume: 114,607

Technical Sentiment Consensus Rating: Hold

Current Market Cap: A$5.76M

For a thorough assessment of IRX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App